Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Asem Albeshri"'
Autor:
Meteb Al‑Foheidi, Asem Albeshri, Safwan Moamenkahan, Abdulmajid Abdullah, Muhannad Abualola, Muath Alharbi, Ahmed Refa, Ali Bayer, Ahmed Shaheen, Syed Aga, Muhammad Khan, Mubarak Al‑Mansour, Ezzeldin Ibrahim
Publikováno v:
Molecular and clinical oncology. 17(1)
The addition of palbociclib (a cyclin-dependent kinase 4/6 inhibitor) to endocrine therapy (ET) has been shown to significantly improve progression-free survival (PFS) and overall survival (OS) among patients with hormone receptor-positive (HR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0d1d435f1071aaaca12031ed1c2d33
https://pubmed.ncbi.nlm.nih.gov/35747598
https://pubmed.ncbi.nlm.nih.gov/35747598
